Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 3 | |
Hold | 17 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast in USD
The 21 analysts offering 12 month price targets for Novartis AG have a median target of 104.29, with a high estimate of 118.20 and a low estimate of 84.43. The median estimate represents a 6.38% increase from the last price of 98.04.
High | 20.6% | 118.20 |
Med | 6.4% | 104.29 |
Low | -13.9% | 84.43 |
Dividends in USD
Div growth (TTM) | 13.28% |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 29, 2024.
Average growth rate | +2.67% |
Average growth rate | +6.48% |
More ▼
Revenue history & estimates in USD
Average growth rate | -1.81% |
Average growth rate | -0.88% |
More ▼